Our previous studies have designed and developed TMZ short-chain ester derivative TMZ4e (TBE) loaded NPs functionalized with anti-EphA3 for glioblastoma targeting, which showed excellent GBM targeting effect and anti-glioma activity (Chu et al., 2018). The gene discussed is EPHA3; the disease is glioblastoma.